{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T02:07:08Z","timestamp":1793066828215,"version":"4.5.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T00:00:00Z","timestamp":1756339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T00:00:00Z","timestamp":1756339200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"DOI":"10.1186\/s12957-025-03980-2","type":"journal-article","created":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T11:36:50Z","timestamp":1756381010000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Prognostic significance of tumor spread through air spaces and lymphovascular invasion in stage I non-small cell lung cancer: implications for adjuvant chemotherapy"],"prefix":"10.1186","volume":"23","author":[{"given":"Tai-Huang","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Yu","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Wen","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shih-Yu","family":"Kao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Wei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jui-Ying","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Hao","family":"Chuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-An","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Chieh","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei-Shuan","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jen-Yu","family":"Hung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inn-Wen","family":"Chong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Jen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,28]]},"reference":[{"key":"3980_CR1","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/S0140-6736(21)00312-3","volume":"398","author":"AA Thai","year":"2021","unstructured":"Thai AA, Solomon BJ, Sequist LV, Gainor JF, Heist RS. Lung cancer. Lancet. 2021;398:535\u201354.","journal-title":"Lancet"},{"key":"3980_CR2","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1016\/j.jtho.2023.06.014","volume":"18","author":"DC Lam","year":"2023","unstructured":"Lam DC, Liam CK, Andarini S, Park S, Tan DSW, Singh N, Jang SH, Vardhanabhuti V, Ramos AB, Nakayama T, et al. Lung cancer screening in asia: an expert consensus report. J Thorac Oncol. 2023;18:1303\u201322.","journal-title":"J Thorac Oncol"},{"key":"3980_CR3","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S2213-2600(23)00338-7","volume":"12","author":"GC Chang","year":"2024","unstructured":"Chang GC, Chiu CH, Yu CJ, Chang YC, Chang YH, Hsu KH, Wu YC, Chen CY, Hsu HH, Wu MT, et al. Low-dose CT screening among never-smokers with or without a family history of lung cancer in taiwan: a prospective cohort study. Lancet Respir Med. 2024;12:141\u201352.","journal-title":"Lancet Respir Med"},{"key":"3980_CR4","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1056\/NEJMoa1312547","volume":"371","author":"WC Black","year":"2014","unstructured":"Black WC, Gareen IF, Soneji SS, Sicks JD, Keeler EB, Aberle DR, Naeim A, Church TR, Silvestri GA, Gorelick J, et al. Cost-effectiveness of CT screening in the National lung screening trial. N Engl J Med. 2014;371:1793\u2013802.","journal-title":"N Engl J Med"},{"key":"3980_CR5","doi-asserted-by":"publisher","first-page":"e754","DOI":"10.1016\/S1470-2045(17)30861-6","volume":"18","author":"M Oudkerk","year":"2017","unstructured":"Oudkerk M, Devaraj A, Vliegenthart R, Henzler T, Prosch H, Heussel CP, Bastarrika G, Sverzellati N, Mascalchi M, Delorme S, et al. European position statement on lung cancer screening. Lancet Oncol. 2017;18:e754\u201366.","journal-title":"Lancet Oncol"},{"key":"3980_CR6","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1056\/NEJMoa1911793","volume":"382","author":"HJ de Koning","year":"2020","unstructured":"de Koning HJ, van der Aalst CM, de Jong PA, Scholten ET, Nackaerts K, Heuvelmans MA, Lammers JJ, Weenink C, Yousaf-Khan U, Horeweg N, et al. Reduced Lung-Cancer mortality with volume CT screening in a randomized trial. N Engl J Med. 2020;382:503\u201313.","journal-title":"N Engl J Med"},{"key":"3980_CR7","doi-asserted-by":"crossref","unstructured":"Chen CL, Hsu JS, Shen YW, Hsu CH, Kao SY, Lai WA, Chuang CH, Liu YW, Lee JY, Chou SH et al. Changes in staging and management of Non-Small cell lung cancer (NSCLC) patients following the implementation of Low-Dose chest computed tomography (LDCT) screening at Kaohsiung medical university hospital. Cancers (Basel). 2024;16(22):3727.","DOI":"10.3390\/cancers16223727"},{"key":"3980_CR8","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1016\/j.athoracsur.2021.04.108","volume":"113","author":"Y Tsutani","year":"2022","unstructured":"Tsutani Y, Imai K, Ito H, Miyata Y, Ikeda N, Nakayama H, Okada M. Adjuvant chemotherapy for High-risk pathologic stage I Non-Small cell lung cancer. Ann Thorac Surg. 2022;113:1608\u201316.","journal-title":"Ann Thorac Surg"},{"key":"3980_CR9","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.lungcan.2023.01.009","volume":"177","author":"Y Lv","year":"2023","unstructured":"Lv Y, Li S, Liu Z, Ren Z, Zhao J, Tao G, Zheng Z, Han Y, Ye B. Impact of surgery and adjuvant chemotherapy on the survival of stage I lung adenocarcinoma patients with tumor spread through air spaces. Lung Cancer. 2023;177:51\u20138.","journal-title":"Lung Cancer"},{"key":"3980_CR10","doi-asserted-by":"publisher","first-page":"e200","DOI":"10.1093\/ejcts\/ezt309","volume":"44","author":"N Yanagawa","year":"2013","unstructured":"Yanagawa N, Shiono S, Abiko M, Ogata SY, Sato T, Tamura G. Prognostic impact and initial recurrence site of lymphovascular and visceral pleural invasion in surgically resected stage I non-small-cell lung carcinoma. Eur J Cardiothorac Surg. 2013;44:e200\u2013206.","journal-title":"Eur J Cardiothorac Surg"},{"key":"3980_CR11","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1016\/j.athoracsur.2016.06.032","volume":"102","author":"BC Gulack","year":"2016","unstructured":"Gulack BC, Yang CJ, Speicher PJ, Yerokun BA, Tong BC, Onaitis MW, D\u2019Amico TA, Harpole DH Jr., Hartwig MG, Berry MF. A risk score to assist selecting lobectomy versus sublobar resection for early stage Non-Small cell lung cancer. Ann Thorac Surg. 2016;102:1814\u201320.","journal-title":"Ann Thorac Surg"},{"key":"3980_CR12","doi-asserted-by":"publisher","first-page":"830470","DOI":"10.3389\/fonc.2022.830470","volume":"12","author":"W Huang","year":"2022","unstructured":"Huang W, Deng HY, Lin MY, Xu K, Zhang YX, Yuan C, Zhou Q. Treatment modality for stage IB peripheral Non-Small cell lung cancer with visceral pleural invasion and =3\u00a0cm in size<\/at. Front Oncol. 2022;12:830470.","journal-title":"Front Oncol"},{"key":"3980_CR13","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1111\/his.14062","volume":"77","author":"AR Shih","year":"2020","unstructured":"Shih AR, Mino-Kenudson M. Updates on spread through air spaces (STAS) in lung cancer. Histopathology. 2020;77:173\u201380.","journal-title":"Histopathology"},{"key":"3980_CR14","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1097\/JTO.0000000000000486","volume":"10","author":"K Kadota","year":"2015","unstructured":"Kadota K, Nitadori JI, Sima CS, Ujiie H, Rizk NP, Jones DR, Adusumilli PS, Travis WD. Tumor spread through air spaces is an important pattern of invasion and impacts the frequency and location of recurrences after limited resection for small stage I lung adenocarcinomas. J Thorac Oncol. 2015;10:806\u201314.","journal-title":"J Thorac Oncol"},{"key":"3980_CR15","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.jtho.2016.09.129","volume":"12","author":"S Lu","year":"2017","unstructured":"Lu S, Tan KS, Kadota K, Eguchi T, Bains S, Rekhtman N, Adusumilli PS, Travis WD. Spread through air spaces (STAS) is an independent predictor of recurrence and lung Cancer-Specific death in squamous cell carcinoma. J Thorac Oncol. 2017;12:223\u201334.","journal-title":"J Thorac Oncol"},{"key":"3980_CR16","doi-asserted-by":"publisher","first-page":"847","DOI":"10.21037\/tlcr.2020.01.06","volume":"9","author":"M Mino-Kenudson","year":"2020","unstructured":"Mino-Kenudson M. Significance of tumor spread through air spaces (STAS) in lung cancer from the pathologist perspective. Transl Lung Cancer Res. 2020;9:847\u201359.","journal-title":"Transl Lung Cancer Res"},{"key":"3980_CR17","doi-asserted-by":"publisher","unstructured":"Chuang CH, Liu YW, Lai WA, Shen YW, Kao SY, Wei YC, Chien CC, Hung HY, Lee JY, Chao MF et al. Impact of spread through air spaces (STAS) on recurrence and surgical trends in stage I Non-Small cell lung cancer: A Real-World cohort study. Kaohsiung J Med Sci. 2025:e70061. https:\/\/doi.org\/10.1002\/kjm2.70061. Online ahead of print.","DOI":"10.1002\/kjm2.70061."},{"key":"3980_CR18","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s12957-025-03707-3","volume":"23","author":"YW Liu","year":"2025","unstructured":"Liu YW, Lai WA, Hung JY, Lee YL, Chiang HH, Lee JY, Li HP, Chou SH, Yang CJ. Spread through air spaces May predict early progression after salvage surgery for EGFR-mutant advanced lung adenocarcinoma treated with targeted therapy. World J Surg Oncol. 2025;23:65.","journal-title":"World J Surg Oncol"},{"key":"3980_CR19","first-page":"664","volume":"40","author":"A Yilmaz","year":"2011","unstructured":"Yilmaz A, Duyar SS, Cakir E, Aydin E, Demirag F, Karakaya J, Yazici U, Erdogan Y. Clinical impact of visceral pleural, lymphovascular and perineural invasion in completely resected non-small cell lung cancer. Eur J Cardiothorac Surg. 2011;40:664\u201370.","journal-title":"Eur J Cardiothorac Surg"},{"key":"3980_CR20","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1097\/JTO.0b013e3182519a42","volume":"7","author":"KA Higgins","year":"2012","unstructured":"Higgins KA, Chino JP, Ready N, D\u2019Amico TA, Berry MF, Sporn T, Boyd J, Kelsey CR. Lymphovascular invasion in non-small-cell lung cancer: implications for staging and adjuvant therapy. J Thorac Oncol. 2012;7:1141\u20137.","journal-title":"J Thorac Oncol"},{"key":"3980_CR21","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.cllc.2011.06.011","volume":"13","author":"C Massabeau","year":"2012","unstructured":"Massabeau C, Filleron T, Wakil G, Rouquette I, Bachaud JM, Leguellec S, Delisle MB, Toulas C, Mazieres J, Cohen-Jonathan Moyal E. The prognostic significance of lymphovascular invasion on biopsy specimens in lung cancer treated with definitive chemoradiotherapy. Clin Lung Cancer. 2012;13:59\u201367.","journal-title":"Clin Lung Cancer"},{"key":"3980_CR22","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/j.athoracsur.2013.11.002","volume":"97","author":"NM Mollberg","year":"2014","unstructured":"Mollberg NM, Bennette C, Howell E, Backhus L, Devine B, Ferguson MK. Lymphovascular invasion as a prognostic indicator in stage I non-small cell lung cancer: a systematic review and meta-analysis. Ann Thorac Surg. 2014;97:965\u201371.","journal-title":"Ann Thorac Surg"},{"key":"3980_CR23","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.jtcvs.2018.02.108","volume":"156","author":"L Okiror","year":"2018","unstructured":"Okiror L, Harling L, Toufektzian L, King J, Routledge T, Harrison-Phipps K, Pilling J, Veres L, Lal R, Bille A. Prognostic factors including lymphovascular invasion on survival for resected non-small cell lung cancer. J Thorac Cardiovasc Surg. 2018;156:785\u201393.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"3980_CR24","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1093\/annonc\/mdi008","volume":"16","author":"M Nakagawa","year":"2005","unstructured":"Nakagawa M, Tanaka F, Tsubota N, Ohta M, Takao M, Wada H, West Japan Study Group for Lung, Cancer S. A randomized phase III trial of adjuvant chemotherapy with UFT for completely resected pathological stage I non-small-cell lung cancer: the West Japan study group for lung cancer surgery (WJSG)--the 4th study. Ann Oncol. 2005;16:75\u201380.","journal-title":"Ann Oncol"},{"key":"3980_CR25","doi-asserted-by":"publisher","first-page":"3270","DOI":"10.1200\/JCO.2005.11.478","volume":"23","author":"KM Pisters","year":"2005","unstructured":"Pisters KM, Le Chevalier T. Adjuvant chemotherapy in completely resected non-small-cell lung cancer. J Clin Oncol. 2005;23:3270\u20138.","journal-title":"J Clin Oncol"},{"key":"3980_CR26","doi-asserted-by":"publisher","first-page":"3552","DOI":"10.1200\/JCO.2007.13.9030","volume":"26","author":"JP Pignon","year":"2008","unstructured":"Pignon JP, Tribodet H, Scagliotti GV, Douillard JY, Shepherd FA, Stephens RJ, Dunant A, Torri V, Rosell R, Seymour L, et al. Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE collaborative group. J Clin Oncol. 2008;26:3552\u20139.","journal-title":"J Clin Oncol"},{"key":"3980_CR27","doi-asserted-by":"publisher","first-page":"S39","DOI":"10.1016\/j.jtcvs.2012.03.039","volume":"144","author":"S Heon","year":"2012","unstructured":"Heon S, Johnson BE. Adjuvant chemotherapy for surgically resected non-small cell lung cancer. J Thorac Cardiovasc Surg. 2012;144:S39\u201342.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"3980_CR28","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.lungcan.2004.11.025","volume":"49","author":"M Imaizumi","year":"2005","unstructured":"Imaizumi M, Study Group of Adjuvant Chemotherapy for Lung C. Postoperative adjuvant cisplatin, vindesine, plus uracil-tegafur chemotherapy increased survival of patients with completely resected p-stage I non-small cell lung cancer. Lung Cancer. 2005;49:85\u201394.","journal-title":"Lung Cancer"},{"key":"3980_CR29","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1186\/s12885-020-07691-7","volume":"20","author":"T Tsuchiya","year":"2020","unstructured":"Tsuchiya T, Kamohara R, Muraoka M, Nagayasu T, Saeki S, Takenoyama M, Suzuki M, Inada K, Tokunaga S, Hayashi T, et al. A single-arm, phase 2 study of adjuvant chemotherapy with oral tegafur-uracil for pathologically lymphovascular invasion positive stage IA non-small cell lung cancer: LOGIK0602 study. BMC Cancer. 2020;20:1192.","journal-title":"BMC Cancer"},{"key":"3980_CR30","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jtho.2015.09.009","volume":"11","author":"P Goldstraw","year":"2016","unstructured":"Goldstraw P, Chansky K, Crowley J, Rami-Porta R, Asamura H, Eberhardt WE, Nicholson AG, Groome P, Mitchell A, Bolejack V, et al. The IASLC lung cancer staging project: proposals for revision of the TNM stage groupings in the forthcoming (Eighth) edition of the TNM classification for lung cancer. J Thorac Oncol. 2016;11:39\u201351.","journal-title":"J Thorac Oncol"},{"key":"3980_CR31","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/S0022-5223(94)70294-2","volume":"108","author":"Y Ichinose","year":"1994","unstructured":"Ichinose Y, Yano T, Yokoyama H, Inoue T, Asoh H, Katsuda Y. The correlation between tumor size and lymphatic vessel invasion in resected peripheral stage I non-small-cell lung cancer. A potential risk of limited resection. J Thorac Cardiovasc Surg. 1994;108:684\u20136.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"3980_CR32","doi-asserted-by":"publisher","first-page":"95","DOI":"10.4103\/ijabmr.IJABMR_500_20","volume":"11","author":"K Grbic","year":"2021","unstructured":"Grbic K, Mujakovic A, Lepara O, Lepara Z, Begic E, Krupic F. Biomarker potential of preoperative tumor size in determination of the lymphovascular invasion in squamous cell lung cancer and lung adenocarcinoma. Int J Appl Basic Med Res. 2021;11:95\u20139.","journal-title":"Int J Appl Basic Med Res"},{"key":"3980_CR33","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1097\/JTO.0000000000000456","volume":"10","author":"J Zhang","year":"2015","unstructured":"Zhang J, Gold KA, Lin HY, Swisher SG, Xing Y, Lee JJ, Kim ES, William WN Jr. Relationship between tumor size and survival in non-small-cell lung cancer (NSCLC): an analysis of the surveillance, epidemiology, and end results (SEER) registry. J Thorac Oncol. 2015;10:682\u201390.","journal-title":"J Thorac Oncol"},{"key":"3980_CR34","doi-asserted-by":"publisher","first-page":"1367200","DOI":"10.3389\/fonc.2024.1367200","volume":"14","author":"M Huang","year":"2024","unstructured":"Huang M, Liu B, Li X, Li N, Yang X, Wang Y, Zhang S, Lu F, Li S, Yan S, Wu N. Beneficial implications of adjuvant chemotherapy for stage IB lung adenocarcinoma exhibiting elevated SUVmax in FDG-PET\/CT: a retrospective study from a single center. Front Oncol. 2024;14:1367200.","journal-title":"Front Oncol"},{"key":"3980_CR35","doi-asserted-by":"publisher","first-page":"100979","DOI":"10.1016\/j.neo.2024.100979","volume":"50","author":"MQ Jiang","year":"2024","unstructured":"Jiang MQ, Qian LQ, Shen YJ, Fu YY, Feng W, Ding ZP, Han YC, Fu XL. Who benefit from adjuvant chemotherapy in stage I lung adenocarcinoma? A multi-dimensional model for candidate selection. Neoplasia. 2024;50:100979.","journal-title":"Neoplasia"},{"key":"3980_CR36","doi-asserted-by":"publisher","first-page":"19137","DOI":"10.1038\/s41598-023-46679-8","volume":"13","author":"YF Cheng","year":"2023","unstructured":"Cheng YF, Chen YL, Liu CC, Lin CM, Tong SS, Wang BY. Adjuvant chemotherapy in pathological node-negative non-small cell lung cancer. Sci Rep. 2023;13:19137.","journal-title":"Sci Rep"},{"key":"3980_CR37","first-page":"819","volume":"26","author":"N Ak","year":"2021","unstructured":"Ak N, Ozkan B, Yenigun MB, Yilmazbayhan D, Toker A, Ferhatoglu F, Yasar A, Dizbay Sak S, Tanju S, Dilege S, et al. The role of adjuvant chemotherapy in resected stage I non - small cell lung cancer: A Turkish oncology group study. J BUON. 2021;26:819\u201329.","journal-title":"J BUON"},{"key":"3980_CR38","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.cllc.2021.10.004","volume":"23","author":"J Li","year":"2022","unstructured":"Li J, Wang Y, Li J, Cao S, Che G. Meta-analysis of lobectomy and sublobar resection for stage I Non-small cell lung cancer with spread through air spaces. Clin Lung Cancer. 2022;23:208\u201313.","journal-title":"Clin Lung Cancer"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-025-03980-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-025-03980-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-025-03980-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T05:01:25Z","timestamp":1757480485000},"score":1,"resource":{"primary":{"URL":"https:\/\/wjso.biomedcentral.com\/articles\/10.1186\/s12957-025-03980-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,28]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3980"],"URL":"https:\/\/doi.org\/10.1186\/s12957-025-03980-2","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,28]]},"assertion":[{"value":"23 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki, and approved by the Institutional Review Board of Kaohsiung Medical University Hospital (KMUH) (KMUHIRB-E(I)-20240126).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The need for informed consent for publication was waived according to the policy of our IRB.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"325"}}